Listen: Julie Rovner Rehashes the ‘Roe’ Decision
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Courts
341 - 360 of 737 Results
-
-
KHN’s ‘What the Health?’: A World Without ‘Roe’
The Supreme Court’s decision overturning Roe v. Wade has created far more questions than it has answered about the continued legality and availability of abortion, as both abortion rights supporters and anti-abortion activists scramble to put their marks on policy. Meanwhile, Congress completes work on its gun bill and the FDA takes up the problem of the next covid-19 booster. Margot Sanger-Katz of The New York Times, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of KHN join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Angela Hart, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about two identical eye surgeries with very different price tags.
-
‘American Diagnosis’ Episode 7: Indigenous Advocates Work for Better Reproductive Care
From forced sterilizations in the 1960s to scant access to abortion care today, barriers to health care threaten Native people’s reproductive autonomy. Episode 7 explores efforts to protect and expand Native Americans’ access to comprehensive reproductive and sexual health care.
-
Genetic Screening Results Just Got Harder to Handle Under New Abortion Rules
Most prenatal genetic tests aren’t performed until after 11 weeks’ gestation, and the time between drawing a sample and getting results may be additional weeks. But new abortion restrictions prevent parents from choosing an abortion when they find out their child has a genetic disease, and make the already difficult decision for them.
By Sara Reardon -
KHN’s ‘What the Health?’: Supreme Court Overturns ‘Roe’
It was expected, but the reality was still jarring: The Supreme Court has formally overturned Roe v. Wade, erasing the nearly 50-year-old guarantee of abortion rights nationwide. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health, Sarah Varney of KHN, and Laurie Sobel, associate director for women’s health policy at KFF, join KHN’s Julie Rovner for this special episode to talk about the decision and what happens next for reproductive health care.
-
‘It’s Not a Haven’: With Limited Capacity for Abortion Care, Minnesota Clinics Brace for Influx
In Minnesota, where abortion rights are protected by the state’s constitution, legal doesn't necessarily mean accessible. The state has just eight clinics that provide abortions, and both providers and advocates say resources available aren’t enough to meet demand as nearby states reduce abortion access.
-
Five Things to Know Now That the Supreme Court Has Overturned Roe v. Wade
By undoing that landmark decision, the law of the land since 1973, the court has empowered states to set their own abortion restrictions — so where people live will determine their level of access.
-
Perspective
After Two Ectopic Pregnancies, I Fear What Might Happen Without Roe v. Wade
A journalism professor’s four failed pregnancies forced her to use procedures or drugs that could soon be difficult to turn to.
-
A Post-‘Roe’ World in Georgia Will Mean More Restrictions — And More Political Battles
Abortion will almost certainly face new restrictions in Georgia. Patients will have a harder time finding services, and providers will have to figure out how to navigate the new landscape. Meanwhile, abortion opponents see the moment as an opportunity to put further restrictions on the procedure.
-
Conservatives on Supreme Court, as Expected, End Nationwide Right to Abortion
The 6-3 decision, telegraphed in May by an unprecedented leak of a draft opinion, eliminates the right to abortion as if it never existed at all.
By Julie Rovner -
Readers and Tweeters Weigh In on Medical Debt, the Obesity Epidemic, and Opioid Battles
KHN gives readers a chance to comment on a recent batch of stories.
-
KHN’s ‘What the Health?’: The FDA Goes After Nicotine
The FDA is using its power to regulate tobacco products — ordering the vaping device Juul off the market and announcing its intention to lower the amount of nicotine in cigarettes and other products. Meanwhile, the Supreme Court rules on Medicare and kidney dialysis, and Congress makes progress on legislation surrounding guns and mental health. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Noam N. Levey about the new KHN-NPR project on the growing impact of medical debt.
-
Two Tennessee Abortion Clinics, Awaiting High-Court Ruling, Grapple With Uncertainty
The landmark Roe v. Wade decision could soon be overturned. Two Knoxville-based providers of reproductive health care wonder how — and if — they will continue to serve their patients.
-
KHN’s ‘What the Health?’: Closing In on Covid Vaccines for ‘The Littles’
The wait is nearly over for parents of kids under 5 as a key advisory committee to the FDA recommends authorizing a covid-19 vaccine for the youngest children. Meanwhile, Congress is struggling to fill in the details of its gun control compromise, and, as the Supreme Court prepares to throw the question of abortion legality back to the states, the number of abortions has been rising. Shefali Luthra of The 19th, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
KHN’s ‘What the Health?’: Taking a Shot at Gun Control
The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare’s trustees board.
-
Misinformation Clouds America’s Most Popular Emergency Contraception
At a moment when half of U.S. states stand poised to outlaw or sharply curtail abortion services, the nation’s most popular emergency contraception brand rests in the unlikely stewardship of two private equity firms.
By Sarah Varney -
Black Women Have Much at Stake in States Where Abortion Access May Vanish
For many women, abortion access has also meant better economic opportunities. But that could change in states that plan to ban most abortion access if the Supreme Court overturns Roe v. Wade. And those constraints could have a big impact on Black women. In Tennessee, Black women have abortions at more than four times the rate of white women.
-
KHN’s ‘What the Health?’: Washington’s Slow Churn
Stemming gun violence is back on the legislative agenda following three mass shootings in less than a month, but it’s hard to predict success when so many previous efforts have failed. Meanwhile, lawmakers must soon decide if they will extend current premium subsidies for those buying health insurance under the Affordable Care Act, and the Biden administration acts, belatedly, on Medicare premiums. Margot Sanger-Katz of the New York Times, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat News join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Michelle Andrews, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a too-common problem: denial of no-cost preventive care for a colonoscopy under the Affordable Care Act.
-
Readers and Tweeters Go to the Mat on Abortion Rights and Perceived Wrongs
KHN gives readers a chance to comment on a recent batch of stories.
-
Skirmishes Over Medication Abortion Renews Debate on State vs. Federal Powers
The Biden administration may have authority to allow the use of abortion pills even in states where the practice could be outlawed, say legal experts.